Alliance snaps up Vamousse range
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Alliance Pharma is poised to grow its presence in the global consumer healthcare market by snapping up the Vamousse head-lice treatment from US-based development firm TyraTech.